Movement Disorders

Resource Center

Polls

POLL

04/08/2024

Do you think deep brain stimulation or botulinum toxin is more effective for the treatment of patients with primary dystonia? Let us know by taking our poll.

04/08/2024

Research Summaries

FDA Alert

FDA Approves First Nonsteroidal Treatment for Patients With Duchenne Muscular Dystrophy

04/18/2024

Anthony Calabro, MA

The FDA approved givinostat, a nonsteroidal oral medication, for treating patients 6 years of age or older with Duchenne muscular dystrophy.

04/18/2024

FDA ALERT

FDA Approves First Treatment for Rare, Degenerative Disease

04/18/2023

Jessica Ganga

The FDA has approved a treatment for Friedreich ataxia after the results of randomized, placebo-controlled study indicate a strong effectiveness in treatment.

04/18/2023

Conference Coverage

An Overview of Parkinson Disease and Movement Disorders

11/18/2022

Jennifer Hui, MD, discusses the different movement disorders and elaborates on idiopathic Parkinson disease, discussing its symptoms and treatment, in her session at the Practical Updates in Primary Care...

11/18/2022

amyotrophic lateral sclerosis

FDA Approves New Medication for Treatment of ALS

10/07/2022

The recent FDA approval of a new oral treatment for patients with amyotrophic lateral sclerosis (ALS) adds another option for individuals who are diagnosed with the non-curable disease.

10/07/2022

Movement Disorders

FDA Approves New Add-on Therapy for Parkinson Disease

08/28/2019

After 4 clinical trials showed the treatment decreased daily “off” time, the FDA approved this new add-on therapy for adults with Parkinson disease.

08/28/2019

October 2024

Current Issue

October 2024

Volume 64

Issue 9